van der Lee, S. J., Conway, O. J., Jansen, I., Carrasquillo, M. M., Kleineidam, L., van den Akker, E., . . . Dalmasso, M. C. (2019). A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Springer.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
van der Lee, Sven J., et al. A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer’s Disease, Dementia with Lewy Bodies and Frontotemporal Dementia, and Increases the Likelihood of Longevity. Springer, 2019.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
van der Lee, Sven J., et al. A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer’s Disease, Dementia with Lewy Bodies and Frontotemporal Dementia, and Increases the Likelihood of Longevity. Springer, 2019.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.